Society Letters

Coalition to Advance Maternal Therapeutics Vaccine Letter to VRBPAC

February 25, 2021

Dear Dr. Sahly:

The undersigned members of the Coalition to Advance Maternal Therapeutics (CAMT) thank members of the Vaccines and Related Biological Products Advisory Committee for their unprecedented efforts to respond to the ongoing COVID-19 pandemic and appreciate the opportunity to submit public comments as you assess an Emergency Use Authorization (EUA) of the Janssen Biotech Inc. COVID-19 vaccine. We appreciate that the Committee has respected patient autonomy by not recommending that pregnant and lactating people be denied access to previously reviewed COVID-19 vaccines, allowing individuals in these populations to make decisions about whether to receive a vaccine based on their own assessment of risk and benefit. We urge you to follow suit for the Janssen Biotech Inc. COVID-19 vaccine and recommend permitting the use of this vaccine by pregnant and lactating people."

arrowRead the Full Letter

Last Updated:
Take Action

Make Your Voice Heard

Take Action
We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.

We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.

Back to top
Short on time?

We'll come to you...

Get updates on the latest breakthroughs, clinical practice guidelines, and career development opportunities, straight to your inbox

Then take the next step: Set up your free website account and get exclusive access to even more great tools & content!